Amerikansk firma forsøger at udvikle middel mod ebola, der bygger på samme teknologi som coronavaccine.
Lyt til artiklen
Henter...
Canada har givet det amerikanske medicinalfirma Moderna tilladelse til at indlede kliniske forsøg med en vaccine mod den variant af ebola, som i øjeblikket spreder sig i DR Congo, oplyser Canadas sundhedsministerium ifølge nyhedsbureauet AFP.
Fase 1-forsøget skal blandt andet vurdere den potentielle vaccines sikkerhed.
Der findes ingen godkendt vaccine eller behandling for Bundibugyo-varianten af ebola, som foreløbig har kostet over 1.700 livet i DR Congo.
Moderna starts human trials for Ebola vaccine amid Congo outbreak
Moderna avvia i test sul vaccino Ebola Bundibugyo mentre l'epidemia in Congo continua
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Health Canada authorizes Moderna clinical trial for new Ebola vaccine candidate
Canada authorizes clinical trials of Moderna Ebola vaccine
Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo | CBC News
Moderna authorized to launch its Ebola vaccine clinical trials in Canada
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
Moderna begins first human trial of Bundibugyo Ebola vaccine
Why Is Moderna Stock Gaining Wednesday? - Moderna (NASDAQ:MRNA)
Moderna has vaccinated the first participants in a trial for a Bundibugyo Ebola vaccine, as the Democratic Republic of Congo…
Moderna ha vaccinato i primi partecipanti a una sperimentazione sul vaccino contro il ceppo Bundibugyo dell’Ebola, mentre la…
Moderna said on Tuesday it has begun a Phase 1 clinical trial of an Ebola vaccine set to target the Bundibugyo strain, which is…
This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has…
TORONTO - Health Canada has authorized Moderna to conduct a clinical trial on a new mRNA vaccine that targets the form of Ebola…
The Phase 1 trial of the mRNA vaccine will assess the candidate vaccine's safety, determine the right dosage range and identify…
